Pioneer in phage-based diagnostics

Twitter Youtube Linkedin Envelope
  • Home
  • About PBD Biotech
    • About
    • Research
    • Blog
  • Phage-based diagnostics
  • Animal Health
    • Animal Health
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Human Health
  • Contact us
  • Home
  • About PBD Biotech
    • About
    • Research
    • Blog
  • Phage-based diagnostics
  • Animal Health
    • Animal Health
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Human Health
  • Contact us

Former dairy farmer joins PBD Biotech’s fight against bovine TB

Jonnie Yewdall, a former dairy farmer, has been appointed Commercial Director at PBD Biotech. The company recently gained funding to take its Actiphage® blood test for bovine TB (bTB) and Johne’s Disease through the validation required for international industry acceptance.
  • May 26, 2021
  • Corporate
Jonnie Yewdall
Jonnie Yewdall

Jonnie has worked in a commercial role in other industries, but he knows first-hand the devastating impact bTB and Johne’s disease can have on farmers through his experiences on a family farm in North Devon, where the herd was decimated by these diseases.

He lost a third of his Guernsey herd following a positive bTB test, and then the replacement animals began to show signs of Johne’s Disease, another mycobacterial disease. Unfortunately, this was the final straw. The emotional toil and the ongoing financial loss were too great and the Yewdalls sold the family farm.

Jonnie says: “I think that Covid-19 has shown the wider business community what it is like to be a dairy farmer at risk from bTB – you are locked-down and you can’t plan or budget.

“I don’t want any farmers to go through what we did, which is why I have joined PBD Biotech. With tools like Actiphage the industry has an opportunity to work together to potentially eradicate these very difficult diseases.”

Actiphage is an extremely specific test, as it detects the DNA from live bacteria in a sample of blood or milk, not just the animal’s immune reaction. It can detect just a few cells; this enables farmers to identify carriers of the disease and remove them from the herd before they become spreaders. This was a recent recommendation from the cattle health certification standards regulatory body Checs.

Actiphage has been approved by APHA for use under special conditions, and when used on-farm as part of a disease management programme it has been proven to eradicate bovine TB.

By recently gaining £2.3M of funding, PBD Biotech is now able to take Actiphage through trials to gain OIE (the World Organisation for Animal Health) validation for the test which will enable international acceptance.

Jonnie sees potential for Actiphage to be used as part of a wider disease management programme to enable farmers to eradicate and then maintain a disease-free status on the farm.

“Actiphage is a blood test for live mycobacteria that gives you a simple yes/no answer. When this is authorised for use on the farm, we could use it in parallel with the statutory testing to manage the infection risk, for example isolating inconclusive reactors pending a further skin test,” he says.

“It could be used as a ‘pre-movement’ test to check animals before they are introduced into a herd and also as a ‘DIVA’ test to differentiate infected from vaccinated animals, paving the way for the introduction of a vaccination programme.”

Share:

Related posts

Loading...
Laboratory Support from PBD Biotech

New qPCR kit offers rapid Mycobacterial detection

July 2, 2025
NEW - Lyophilised qPCR Kit for Mycobacterium tuberculosis Complex Detection
Laboratory Support from PBD Biotech

New qPCR kit offers rapid Mycobacterial detection

July 2, 2025
NEW - Lyophilised qPCR Kit for Mycobacterium tuberculosis Complex Detection
Actiphage TB diagnostic releases bacterial DNA for qPCR

Commercial opportunities with PBD Biotech

June 30, 2025
PBD Biotech is actively seeking commercial partnerships to exploit its patented technology.
Actiphage TB diagnostic releases bacterial DNA for qPCR

Commercial opportunities with PBD Biotech

June 30, 2025
PBD Biotech is actively seeking commercial partnerships to exploit its patented technology.
mycobacteria

Work by phage pioneers celebrated in World Antimicrobial Awareness Week

November 23, 2023
Dr Ben Swift has been awarded a Horizon award by AMI for his ground-breaking work developing a phage-based diagnostic for tuberculosis.
mycobacteria

Work by phage pioneers celebrated in World Antimicrobial Awareness Week

November 23, 2023
Dr Ben Swift has been awarded a Horizon award by AMI for his ground-breaking work developing a phage-based diagnostic for...
Certificate of Grant (web)

Actiphage TB patent granted in South Africa

November 14, 2023
Grant of a patent has been awarded to PBD Biotech for its Actiphage diagnostic for incipient tuberculosis in South Africa, this complements the regional West Africa patent gained earlier this year.
Certificate of Grant (web)

Actiphage TB patent granted in South Africa

November 14, 2023
Grant of a patent has been awarded to PBD Biotech for its Actiphage diagnostic for incipient tuberculosis in South Africa, this complements...
1 2 Next »

developers of phage-based diagnostics

Contact Us

Registered Company Address
B4 Parkside Knowledge Gateway
Nesfield Road
Colchester
CO4 3ZL
United Kingdom

info@pbdbio.com

BIVDA member 2023
Twitter Youtube Linkedin

Privacy and cookies policy

© 2025 PBD Biotech Ltd

design: out of house